Sandra Levy
ARTICLES BY THIS AUTHOR
- 9/30/2020
Eton gets FDA green light for Alkindi Sprinkle
Eton’s Alkindi Sprinkle is the first and only granular hydrocortisone formulation for adrenocortical insufficiency for children approved by the Food and Drug Administration. - 9/30/2020
Dr. Reddy's intros generic Sensipar
The Sensipar brand and generic had a market value of approximately $312 million for the most recent 12 months ended July 2020, according to IQVIA. - 9/29/2020
Schnuck Markets deploys Tally robot to more locations
Schnuck Markets is launching Simbe Robotics’ technology in an additional 46 stores, leveraging Tally’s real-time data to improve the shopping experience in 62 locations. - 9/29/2020
Hy-Vee pharmacies offer childhood vaccinations, flu shots
Childhood vaccinations now are available at more than 270 Hy-Vee pharmacy locations in eight states. - 9/28/2020
AAM report: Generic savings totaled $313B in 2019
The U.S. healthcare system saved $313 billion in 2019 due to low-cost generics, according to a new report by the Association for Accessible Medicines. - 9/28/2020
Teva offers generic Tecfidera
Teva’s generic is available in dosage strengths of 120 mg and 240 mg, as well as in bottle sizes of 14 capsules and 60 capsules, respectively. - 9/28/2020
NACDS flu ads to air during presidential debate week in Washington, D.C.
The National Association of Chain Drug Stores’ flu vaccine message will air in Washington, D.C., on presidential debate day and debate reaction day. - 9/28/2020
GSK gets FDA blessing for new indication for Nucala
GSK’s Nucala has received the Food and Drug Administration’s approval for patients with HES, a group of rare blood disorders. - 9/28/2020
Dr. Reddy's debuts Tecfidera generic
The Tecfidera brand and generic had a market value of roughly $3.8 billion for the most recent 12 months ended June 2020, according to IQVIA. - 9/24/2020
Vertex obtains FDA blessing for new Kalydeco indication
Vertex's Kalydeco, which was first approved in 2012, has received the FDA nod for an expanded indication that will provide a Cystic Fibrosis treatment for children ages four months to less than six months old.
